Cooley LLP is serving as U.S. legal advisor, and Ogier is serving as Cayman Islands legal advisor to PSI Group Holdings Ltd in the transaction, while...
PSI Group’s Business Combination with AIB Acquisition Corporation
Olema Pharmaceuticals’ $150 Million At-the-Market Offering
Cooley advised Olema Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised TD Cowen, as sales agent. Olema Pharmaceuticals ((“Olema”, Nasdaq: OLMA) announced its $150...
Voyager Therapeutics’ $100 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr advised Voyager Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Voyager Therapeutics, Inc. (Nasdaq: VYGR) announced an underwritten public offering...
AstraZeneca’s $1.2 Billion Acquisition of Gracell Biotechnologies
Freshfields Bruckhaus Deringer and Maples Group are advising AstraZeneca on the transaction, and Cooley and Harney Westwood & Riegels are advising Gracell Biotechnologies. AstraZeneca announced it...
Bristol Myers Squibb’s $4.1 Billion Acquisition of RayzeBio
Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...
SystImmune’s Licensing and Collaboration Agreement with Bristol Myers Squibb
Cooley advised SystImmune on the transaction. SystImmune announced its exclusive license and collaboration agreement with Bristol Myers Squibb (NYSE: BMY) for SystImmune’s BL-B01D1. Under the terms of...
Roche’s Acquisition of Carmot Therapeutics
Honigman and Cooley advised Carmot Therapeutics on the transaction. Carmot Therapeutics, Inc. (Carmot) announced its definitive merger agreement pursuant to which Roche will acquire Carmot. Under the...
CARGO Therapeutics’ $281.3 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
Jiangsu Hengrui Pharmaceuticals’ License Agreement With Elevar Therapeutics
Cooley advised Jiangsu Hengrui Pharmaceuticals on the deal. Jiangsu Hengrui Pharmaceuticals (“Hengrui”), a global pharmaceutical company focused on scientific and technological innovation, signed a global license agreement...
Jiangsu Hengrui Pharmaceuticals’ License Agreement With Merck
Cooley advised Jiangsu Hengrui Pharmaceuticals on the deal. Jiangsu Hengrui Pharmaceuticals (“Hengrui”), a global pharmaceutical company focused on scientific and technological innovation, announced its strategic collaboration...
ALX Oncology’s $63 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the offering, and Cooley advised the underwriters. ALX Oncology Holdings Inc. (Nasdaq:ALXO) announced the pricing...
Roivant Sciences’ $200 Million Common Shares Offering
Davis Polk & Wardwell and Conyers Dill & Pearman advised Roivant Sciences Ltd. on the offering. Cooley advised Immunovant on the transaction. Roivant Sciences Ltd. (Nasdaq:ROIV)...